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Abstract 
Background: Familial adenomatous polyposis (FAP) is an autosomal dominantly inherited 
syndrome characterized by the development of numerous polyps in the colon and rectum. If 
left untreated, the affected patients inevitably develop colon cancer by the age of 40 years. A 
resection of the colon (colectomy) or of the colon and rectum (proctocolectomy) is needed 
to minimize the risk of cancer. Case Presentation: We report a case of FAP through three 
generations of a single family, in which the grandmother and granddaughter underwent total 
colectomy with ileoanal anastomosis and did not develop colon cancer, while the son 
underwent subtotal colectomy with ileorectal anastomosis and developed recurrent rectal 
cancer. Data regarding timely surgery, surveillance, and chemoprevention are discussed. 
Conclusion: The FAP phenotype determines the type of treatment. In severe polyposis, 
proctocolectomy with ileoanal anastomosis seems to be the optimal method for minimizing 
the risk of cancer development. This case report advocates complete rectal removal, 
especially in cases of poor patient compliance with colonoscopic surveillance. 
© 2014 S. Karger AG, Basel 
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Familial adenomatous polyposis (FAP) is an autosomal dominantly inherited syndrome 
characterized by the development of numerous (hundreds to thousands) polyps in the 
epithelium of the large intestines [1]. Its prevalence is approximately 3–10/100,000, 
affecting both sexes equally, with symptoms clinically manifesting themselves by the late 
teens and in the twenties [2]. The syndrome has a strong penetrance and in a typical course, 
all patients develop colorectal cancer, except when they are diagnosed and treated at an 
early stage. These polyps start out as adenomas in childhood, predominantly in the 
rectosigmoid colon, and during the second and third decades of life a malignant transfor-
mation to colorectal cancer occurs. The most common symptoms manifest in the advanced 
stage of FAP and include rectal bleeding, anemia, abdominal pain, tenesmus, and diarrhea. In 
the majority of FAP patients, a genetic disorder resulting from a germline mutation in the 
adenomatous polyposis gene (APC gene) is responsible for the syndrome [3]. 
Other common clinical features in patients with FAP include multiple gastric fundic 
gland polyps, duodenal, periampullar or ampullar adenomas, while extraintestinal features 
are desmoid tumors, congenital hypertrophy of the retinal pigment epithelium, epidermoid 
cysts, osteomas and thyroid cancer [4]. 
Of all the colorectal cancer cases worldwide, FAP accounts for less than 1%. The majori-
ty of patients with FAP develop colorectal cancer by the age of 40 years. Therefore, different 
surgical strategies have been adopted to prevent cancer development in the large bowel 
mucosa. Herein we discuss these options based on a three-generation case. 
Case Presentation 
All surgical interventions, histology, extracolonic manifestations, and mutations record-
ed in the affected family members are presented in a timeline fashion in table 1. 
Case 1 
Based on colonoscopically confirmed multiple polyps in the colon and rectum at the age 
of 11 coupled with a family history, a male patient underwent subtotal colectomy with 
ileorectal anastomosis. At 39 years of age, the patient underwent restorative proctectomy 
with ileal pouch-anal anastomosis. Histopathology revealed hundreds of polyps with two 
adenocarcinomas found in the specimen – both Dukes A, Astler Coller B1 and G2 – and 
multiple polyps with low- to high-grade dysplasia (fig. 1, fig. 2). In 2010, at the age of 41, the 
patient was referred for genetic testing from the Oncology Department where he was 
receiving 5-fluoropirimidine/leucovorin and radiation as adjuvant treatment after Miles 
procedure for recurrent rectal cancer (a tumor 3 cm in diameter was found on ileoanal 
anastomosis, with 3 positive lymph nodes out of 4 isolated). The 2-year follow-up CT 
showed multiple lung and liver metastases and the patient was treated with a capecitabine-
irinotecan (XELIRI) plus bevacizumab protocol as first-line chemotherapy for metastatic 
colorectal cancer. 
Case 2 
The first clinically confirmed family member was patient No. 1’s mother. In 1972, the 
Caucasian female, who was 24 years old at the time, underwent her first procedure, which 
was Miles procedure for rectal cancer located at 13 cm from the anal verge. On pathology 
specimen, several polyps with high-grade dysplasia were found in the rectal ampulla. At the 
 Case Rep Oncol 2014;7:349–356 
DOI: 10.1159/000363221 
 
© 2014 S. Karger AG, Basel 
www.karger.com/cro 
Murgic et al.: Familial Adenomatous Polyposis in Three Generations of a Single Family: 




age of 33, a correction of sigmoidostomy was performed due to a prolapse of the stoma, and 
multiple polyps were found in the specimen. Clinical diagnosis of FAP was established. At the 
age of 42, total colectomy with Kock’s reservoir was performed (around 50 polyps with low- 
to high-grade dysplasia were recorded on pathology report). Further follow-up was carried 
out according to FAP protocols, and at the age of 55, polyps were detected in the gastric 
antrum and duodenum and a biopsy revealed adenoma. At the age of 57, 4 large periampul-
lar polyps were removed, one of which comprised adenocarcinoma in situ. At the age of 63 
and 65, another 2 polyps, gastric and duodenal, were removed. At the age of 45, adenoma of 
the parathyroid had been removed. 
Case 3 
After the clinical diagnosis was established in the family, other family members were 
screened. In 2010, patient No. 1’s 13-year-old daughter was routinely followed by colonos-
copy. One year later, after high-grade dysplasia was confirmed by a polyp biopsy, total 
proctocolectomy with ileoanal anastomosis was performed (pathology examination of the 
specimen revealed more than 50 polyps, with one comprising adenocarcinoma in situ). In 
2012, the patient underwent total thyroidectomy due to papillary thyroid cancer and 
duodenal polypectomy for duodenal tubular adenoma. No other extracolonic disease or 
intestinal recurrences were found. 
The Family 
Retrospectively, the family history revealed that patient No. 2’s mother had had colon 
cancer at the age of 41 and that her father had died of gastric cancer at the age of 69. 
However, medical records could not be retrieved. Patient No. 1’s 31-year-old brother and his 
older daughter (14 years old) had 2 and 3 polyps on colonoscopy, respectively (adenomas 
on biopsy), while his younger daughter (12 years old) had negative colonoscopy. 
Mutations 
A family pedigree chart (fig. 3) was then constructed and genetic testing was offered to 
the entire family: patients No. 1–3, patient No. 1’s brother and his daughters. In patients No. 
1–3, a 2805C>G substitution was detected. The mutation causes premature APC protein 
termination at the position 935Y>X. The other family members were mutation-free. 
Discussion 
Herein a three-generation case of FAP in a single family is presented, in which the 
grandmother, her son and her granddaughter had a clinical presentation of FAP. The 
grandmother and granddaughter remained disease-free after they had undergone total 
proctocolectomy, but the son developed recurrent colon cancer on ileoanal anastomosis and 
later metastatic disease. They were all subjected to the screening and follow-up recom-
mended for FAP patients, and genetic testing revealed a 2805C>G substitution, which results 
in a truncated protein. 
Most individuals with FAP will develop colon cancer by the age of 40; therefore, prophy-
lactic surgery is generally recommended before the age of 25. There are 3 main surgical 
options for patients with FAP: (1) total proctocolectomy with Brooke ileostomy; (2) subtotal 
colectomy with ileorectal anastomosis, and (3) restorative proctocolectomy with the 
formation of an ileal reservoir and ileoanal anastomosis [5, 6]. The treatment of choice is 
total colectomy; however, the removal or preservation of the rectum is a matter of contro-
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versy. The decision to remove the rectum is influenced by the number of polyps in the 
rectum as well as by the family history. If there are only few polyps in the rectum, total 
colectomy with ileorectal anastomosis may be recommended. If the rectum is involved, then 
restorative proctocolectomy with ileal pouch-anal anastomosis is the treatment of choice [7]. 
Prophylactic surgery significantly improves the outcome of patients with FAP. 
In the granddaughter’s resected colon, numerous polyps were found, microscopically 
demonstrating high-grade epithelial dysplasia as the last stage in the multistep process of 
colorectal carcinogenesis. These features probably displayed a more aggressive mutation 
phenotype since she was only 14 years old at the time of surgery. Generally, prophylactic 
cancer-preventive colorectal surgery is recommended by the late teens or early twenties [8]. 
Half of FAP patients develop adenomas by 15 years of age but cancer development at this 
age is uncommon. Generally, cancer starts to develop a decade after the appearance of the 
polyps [9]. The optimal surgical procedure is proctocolectomy with pouch formation and 
ileoanal anastomosis since it completely removes all large bowel mucosa as potential origin 
of cancer and thereby minimizes the risk of malignancy, while preserving bowel function. 
For most patients, this is the procedure of choice [10]. On the other hand, patients who 
undergo ileorectal anastomosis are at risk, varying from 13 to 59%, of developing rectal 
adenomas and carcinomas after 25 years and they demand lifelong rectal surveillance [5]. 
Moreover, in a subset of patients having undergone proctocolectomy, endoscopic annual 
surveillance of the pouch and transitional anal zone is essential since many studies have 
demonstrated that premalignant changes and invasive adenocarcinomas are found in the 
ileoanal pouch even after restorative proctocolectomy [11–13]. 
Patient No. 1 omitted colonoscopic surveillance between the last two surgical proce-
dures, which might explain the extent of local recurrence. Colonoscopy and prophylactic 
colectomy are the primary strategies to prevent colon cancer or detect it at an early stage. 
The American Gastroenterology Association recommends annual sigmoidoscopy in patients 
with classic FAP and at-risk relatives starting at the age of 10–12 years. Patients with 
adenomatous polyps found on sigmoidoscopy should undergo a full colonoscopy and 
random biopsies to establish the severity of the polyposis [14]. The family members who are 
mutation-free will be surveyed by the protocols for the general population. Implementation 
of genetic testing that would result in standard protocols is still a matter of debate, since the 
tests are still not widely available and patients are not referred when indicated, leaving 
room for improvement in FAP treatment. 
The reason why the grandmother did not have a regular follow-up or a more aggressive 
surgical treatment remained obscure even after a careful review of her history. We believe it 
might both be due to the unawareness of this syndrome at the time of the first operation and 
surgery planning based on sigmoidoscopy. On the other hand, the patient had not been 
compliant with regular follow-up until the diagnosis of FAP was made and its implication 
explained. This issue stresses the critical importance of lifelong follow-up and responsibility 
for both patients and physicians to adhere to when dealing with FAP. Several studies have 
demonstrated that a regular use of nonsteroidal anti-inflammatory drugs and selective COX-
2 inhibitors can reduce the polyp number and size in patients with FAP [15–17]. Upon these 
results, celecoxib was approved as adjunctive preventive treatment in patients with FAP, 
besides inevitable endoscopic surveillance and surgical intervention. The successful 
management of colonic disease implies a continuous surveillance of extracolonic disease. 
Patient No. 2 had surgery for parathyroid adenoma and patient No. 3 for thyroid cancer, 
while patient No. 2 had ampullar cancer endoscopically removed. Multidisciplinarity and, 
again, long-term surveillance is essential for these patients. 
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Patient compliance with regular and strict surveillance is an important factor when 
deciding on the optimal type of prophylactic surgery. Patients who are not adherent to 
surveillance should undergo proctocolectomy with ileal pouch-anal anastomosis. Timing and 
type of preventive surgery as well as compliance with preventive strategies and strict 
follow-up are essential for minimizing the risk of cancer development in patients with FAP. 
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Table 1. Timeline of surgical interventions for the affected family members 
                Case 2 (grandmother)  Case 1 (son)  Case 3 (granddaughter) 
              Age at diagnosis 
(years) 
 24  11  13 
              First procedure  At 24 years abdominoperineal 
resection; histology: rectal 
adenocarcinoma with few polyps 
 At 11 years subtotal colectomy with 
ileorectal anastomosis; histology: 
multiple polyps 
 At 14 years total proctocolectomy 
with ileoanal anastomosis; histology: 
FAP, countless polyps with  
high-grade dysplasia and one 
carcinoma in situ 
              Second procedure  At 33 years correction of 
sigmoidostomy for prolapse; 
histology: few polyps 
 At 39 years restorative proctectomy 
with ileal pouch-anal anastomosis; 
histology: multiple polyps with  
high-grade dysplasia; two 
adenocarcinomas (T2N0Mx G2, 
T1N0Mx G2)  
 – 
              Third procedure  At 42 years total colectomy with 
Kock’s reservoir; histology: colon 
polyposis with numerous 
tubulovilluos adenomas with  
high-grade dysplasia 
 At 41 years abdominoperineal 
resection; histology: recurrent rectal 
adenocarcinoma (LNR 3/4) followed 
by RT/5FU/L 
 – 
              Extra-colonic disease  At 45 years adenoma of parathyroid 
was removed; histology: parathyroid 
adenoma 
At 55 years duodenal polypectomy; 
histology: adenovillous polyp  
At 57 years duodenal polypectomy; 
histology: villous adenoma with  
adenocarcinoma  
At 63 years gastric polyp; histology: 
adenomatous polyp with high-grade 
dysplasia 
At 65 years duodenal polyp;  
histology: adenomatous polyp 
 At 43 years progression with 
multiple liver and lung metastases 
followed by XELIRI-bevacizumab 
chemotherapy 
 At 15 years total thyroidectomy;  
histology: papillary thyroid cancer 
At 15 years polypectomy of 
duodenal polyp; histology: tubular 
adenoma 
           Genetic testing in all three patients revealed a 2805C>G substitution. LNR = Lymph node ratio; RT/5FU/L = radiotherapy concomitantly with 
5-FU and leucovorin chemotherapy; XELIRI = capecitabine plus irinotecan. 
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Fig. 2. a Villous adenoma with high-grade epithelial dysplasia (HE. ×40). b Adenocarcinoma infiltrating 
the submucosa (HE. ×40).  
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Fig. 3. Family pedigree chart. 
 
